| กรอบเวลา | ราคาที่คาดการณ์ | อดีต | ประวัติศาสตร์ | ข้อมูลเชิงลึก |
|---|---|---|---|---|
| พรุ่งนี้ | $13.24 ▲ +1.33% | เมื่อวาน | $13.00 ▼ -0.56% | Tomorrow's Entrada Therapeutics Inc. Common Stock (TRDA) setup is anchored to $13.07 and targets $13.24 (+1.33%). The near-term read is upside; watch $13.46 / $12.68 because daily realized volatility is about 6.84%. |
Tomorrow's Entrada Therapeutics Inc. Common Stock (TRDA) setup is anchored to $13.07 and targets $13.24 (+1.33%). The near-term read is upside; watch $13.46 / $12.68 because daily realized volatility is about 6.84%. | ||||
| สัปดาห์ | $13.61 ▲ +4.12% | สัปดาห์ที่แล้ว | $12.84 ▼ -1.73% | The 7-day Entrada Therapeutics Inc. Common Stock model moves from $12.84 to $13.61 (+4.12%). It gives upside momentum context for this stock, so breaks around $13.46 / $12.68 matter more than a single tick. |
The 7-day Entrada Therapeutics Inc. Common Stock model moves from $12.84 to $13.61 (+4.12%). It gives upside momentum context for this stock, so breaks around $13.46 / $12.68 matter more than a single tick. | ||||
| เดือน | $14.22 ▲ +8.79% | เดือนที่แล้ว | $12.59 ▼ -3.69% | The 1-month Entrada Therapeutics Inc. Common Stock target is $14.22 (+8.79%), compared with the live reference near $13.07. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Entrada Therapeutics Inc. Common Stock target is $14.22 (+8.79%), compared with the live reference near $13.07. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| ปี | $15.13 ▲ +15.77% | ปีที่แล้ว | $12.20 ▼ -6.62% | The 1-year Entrada Therapeutics Inc. Common Stock scenario points to $15.13 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Entrada Therapeutics Inc. Common Stock scenario points to $15.13 (+15.77%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 ปี | $17.27 ▲ +32.14% | 5 ปีที่แล้ว | $11.31 ▼ -13.50% | The 5-year Entrada Therapeutics Inc. Common Stock view is $17.27 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Entrada Therapeutics Inc. Common Stock view is $17.27 (+32.14%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| ตัวบ่งชี้ | ค่า | สัญญาณ |
|---|---|---|
| Price | $13.07 | Mid |
| Daily Change | -3.61% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 65% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $13.07 | Daily Change | -3.61% |
| Market Cap | $500.38M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.